Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Claude Reubi

Showing results (21-30 of 185) with videos related to

Pageof 19
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2003
Neuropeptide Y receptor expression in human primary ovarian neoplasmsMeike Körner, Beatrice Waser, Jean Claude Reubi
Neuroendocrinology|January 17, 2015
Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?Meike Körner, Beatrice Waser, Jean Claude Reubi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paragangliaMeike Körner, Beatrice Waser, Jean Claude Reubi
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasmsAchim Fleischmann, Beatrice Waser, Jean Claude Reubi
Endocrine-Related Cancer|May 30, 2009
High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applicationsAchim Fleischmann, Beatrice Waser, Jean Claude Reubi
Endocrinology and Metabolism Clinics of North America|November 25, 2010
Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a reviewEmanuel Christ, Damian Wild, Jean Claude Reubi
Pituitary|June 7, 2013
Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenomaJan Komor, Jean Claude Reubi, Emanuel R Christ
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targetingMeike Körner, Martin Stöckli, Beatrice Waser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2016
Highly Increased 125I-JR11 Antagonist Binding In Vitro Reveals Novel Indications for sst2 Targeting in Human CancersJean Claude Reubi, Beatrice Waser, Helmut Mäcke, et al.
Journal of Medicinal Chemistry|June 15, 2007
New sst4/5-selective somatostatin peptidomimetics based on a constrained tryptophan scaffoldDebby Feytens, Renzo Cescato, Jean Claude Reubi, et al.
Pageof 19

Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2003
Neuropeptide Y receptor expression in human primary ovarian neoplasmsMeike Körner, Beatrice Waser, Jean Claude Reubi
Neuroendocrinology|January 17, 2015
Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?Meike Körner, Beatrice Waser, Jean Claude Reubi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paragangliaMeike Körner, Beatrice Waser, Jean Claude Reubi
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasmsAchim Fleischmann, Beatrice Waser, Jean Claude Reubi
Endocrine-Related Cancer|May 30, 2009
High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applicationsAchim Fleischmann, Beatrice Waser, Jean Claude Reubi
Endocrinology and Metabolism Clinics of North America|November 25, 2010
Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a reviewEmanuel Christ, Damian Wild, Jean Claude Reubi
Pituitary|June 7, 2013
Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenomaJan Komor, Jean Claude Reubi, Emanuel R Christ
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targetingMeike Körner, Martin Stöckli, Beatrice Waser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2016
Highly Increased 125I-JR11 Antagonist Binding In Vitro Reveals Novel Indications for sst2 Targeting in Human CancersJean Claude Reubi, Beatrice Waser, Helmut Mäcke, et al.
Journal of Medicinal Chemistry|June 15, 2007
New sst4/5-selective somatostatin peptidomimetics based on a constrained tryptophan scaffoldDebby Feytens, Renzo Cescato, Jean Claude Reubi, et al.
Pageof 19